Literature DB >> 30359558

Revised Australian national guidelines for colorectal cancer screening: family history.

Mark A Jenkins1, Driss Ait Ouakrim2, Alex Boussioutas3, John L Hopper2, Hooi C Ee4, Jon D Emery2, Finlay A Macrae3, Albert Chetcuti5, Laura Wuellner6, D James B St John7.   

Abstract

INTRODUCTION: Screening is an effective means for colorectal cancer prevention and early detection. Family history is strongly associated with colorectal cancer risk. We describe the rationale, evidence and recommendations for colorectal cancer screening by family history for people without a genetic syndrome, as reported in the 2017 revised Australian guidelines. Main recommendations: Based on 10-year risks of colorectal cancer, people at near average risk due to no or weak family history (category 1) are recommended screening by immunochemical faecal occult blood test (iFOBT) every 2 years from age 50 to 74 years. Individuals with moderate risk due to their family history (category 2) are recommended biennial iFOBT from age 40 to 49 years, then colonoscopy every 5 years from age 50 to 74 years. People with a high risk due to their family history (category 3) are recommended biennial iFOBT from age 35 to 44 years, then colonoscopy every 5 years from age 45 to 74 years. Changes in management as a result of the guidelines: By 2019, the National Bowel Cancer Screening Program will offer all Australians free biennial iFOBT screening from age 50 to 74 years, consistent with the recommendations in these guidelines for category 1. Compared with the 2005 guidelines, there are some minor changes in the family history inclusion criteria for categories 1 and 2; the genetic syndromes have been removed from category 3 and, as a consequence, colonoscopy screening is now every 5 years; and for categories 2 and 3, screening begins with iFOBT for people aged 40 and 35 years, respectively, before transitioning to colonoscopy after 10 years.

Entities:  

Keywords:  Colorectal neoplasms; Guidelines as topic; Mass screening; Preventive medicine

Mesh:

Year:  2018        PMID: 30359558

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

1.  Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer.

Authors:  Samir Gupta; Balambal Bharti; Dennis J Ahnen; Daniel D Buchanan; Iona C Cheng; Michelle Cotterchio; Jane C Figueiredo; Steven J Gallinger; Robert W Haile; Mark A Jenkins; Noralane M Lindor; Finlay A Macrae; Loïc Le Marchand; Polly A Newcomb; Stephen N Thibodeau; Aung Ko Win; Maria Elena Martinez
Journal:  Cancer       Date:  2020-04-20       Impact factor: 6.860

2.  Heterogeneity in the psychosocial and behavioral responses associated with a diagnosis of suspected Lynch syndrome in women with endometrial cancer.

Authors:  Sowmya Jonnagadla; Sharelle L Joseland; Sibel Saya; Nicole den Elzen; Joanne Isbister; Ingrid M Winship; Daniel D Buchanan
Journal:  Hered Cancer Clin Pract       Date:  2022-07-15       Impact factor: 2.164

3.  Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.

Authors:  Aviv Gafni; Gillian S Dite; Erika Spaeth Tuff; Richard Allman; John L Hopper
Journal:  PLoS One       Date:  2021-09-15       Impact factor: 3.752

Review 4.  A scoping review of risk-stratified bowel screening: current evidence, future directions.

Authors:  J M Cairns; S Greenley; O Bamidele; D Weller
Journal:  Cancer Causes Control       Date:  2022-03-20       Impact factor: 2.532

5.  Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia.

Authors:  Eleonora Feletto; Jie-Bin Lew; Joachim Worthington; Emily He; Michael Caruana; Katherine Butler; Harriet Hui; Natalie Taylor; Emily Banks; Karen Barclay; Kate Broun; Alison Butt; Rob Carter; Jeff Cuff; Anita Dessaix; Hooi Ee; Jon Emery; Ian M Frayling; Paul Grogan; Carol Holden; Christopher Horn; Mark A Jenkins; James G Kench; Maarit A Laaksonen; Barbara Leggett; Gillian Mitchell; Susan Morris; Bonny Parkinson; D James St John; Linda Taoube; Katherine Tucker; Melanie A Wakefield; Robyn L Ward; Aung Ko Win; Daniel L Worthley; Bruce K Armstrong; Finlay A Macrae; Karen Canfell
Journal:  BMJ Open       Date:  2020-06-21       Impact factor: 2.692

Review 6.  Colorectal Cancer in Brunei Darussalam: An Overview and Rationale for National Screening Programme.

Authors:  Mei Ann Lim; Vui Heng Chong; Sok King Ong; Ya Chee Lim
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

7.  The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program.

Authors:  Sibel Saya; Jon D Emery; James G Dowty; Jennifer G McIntosh; Ingrid M Winship; Mark A Jenkins
Journal:  JNCI Cancer Spectr       Date:  2020-07-18

Review 8.  Current and future colorectal cancer screening strategies.

Authors:  Aasma Shaukat; Theodore R Levin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-03       Impact factor: 73.082

9.  The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.

Authors:  Sibel Saya; Lucy Boyd; Patty Chondros; Mairead McNamara; Michelle King; Shakira Milton; Richard De Abreu Lourenco; Malcolm Clark; George Fishman; Julie Marker; Cheri Ostroff; Richard Allman; Fiona M Walter; Daniel Buchanan; Ingrid Winship; Jennifer McIntosh; Finlay Macrae; Mark Jenkins; Jon Emery
Journal:  Trials       Date:  2022-09-27       Impact factor: 2.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.